EP2011536A1 — Inhaler
Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2009-01-07 · 17y expired
What this patent protects
An inhaler (1) for delivery of a powder-form inhalation formulation from a blister strip (2) with a plurality of blister pockets (3) is proposed. The used part of the blister strip with empty blister pockets is wound onto a drum (9) which is driven via a gear mechanism (10) which…
USPTO Abstract
An inhaler (1) for delivery of a powder-form inhalation formulation from a blister strip (2) with a plurality of blister pockets (3) is proposed. The used part of the blister strip with empty blister pockets is wound onto a drum (9) which is driven via a gear mechanism (10) which is coupled to the drum via a spring (15). The spring allows a compensation of different peripheral speeds of the wound-up part.
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.